This Nasdaq Vaccine Stock Just Got a Big Boost -- and Another Nasdaq Vaccine Stock Deserves the CreditThe Motley Fool • 07/16/21
MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500InvestorPlace • 07/16/21
Moderna gets the ultimate Wall Street validation: It's being added to the S&P 500CNN Business • 07/16/21
Moderna spikes 8% to record highs after it is selected to be added to S&P 500Business Insider • 07/16/21
Moderna Is Now More Valued Than Gilead, GlaxoSmithKline: How Long Did COVID-19 Vaccine Maker Take To Hit $100B?Benzinga • 07/15/21
Moderna to Report Second Quarter Financial Results on Thursday, August 5, 2021Business Wire • 07/15/21
What Pfizer, BioNTech, and Moderna Are Doing to Fight the Deadly Delta VariantThe Motley Fool • 07/14/21